The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases

Clin Sci (Lond). 2020 Jun 26;134(12):1305-1318. doi: 10.1042/CS20200075.

Abstract

Podocyte injury and loss contribute to proteinuria, glomerulosclerosis and eventually kidney failure. Recent studies have demonstrated that the loss of Kruppel-like factor 15 (KLF15) in podocytes increases the susceptibility to injury; however, the mechanism underlying the protective effects on podocyte injury remains incompletely understood. Herein, we showed that KLF15 ameliorates podocyte injury through suppressing NFAT signaling and the salutary effects of the synthetic glucocorticoid dexamethasone in podocyte were partially mediated by the KLF15-NFATc1 axis. We found that KLF15 was significantly reduced in glomerular cells of proteinuric patients and in ADR-, LPS- or HG-treated podocyets in vitro. Overexpression of KLF15 attenuated podocyte apoptosis induced by ADR, LPS or HG and resulted in decreased expression of pro-apoptotic Bax and increased expression of anti-apoptotic Bcl-2. Conversely, the flow cytometry analysis and TUNEl assay demonstrated that loss of KLF15 accelerated podocyte apoptosis and we further found that 11R-VIVIT, a specific NFAT inhibitor, and NFATc1-siRNA rescued KLF15-deficient induced podocyte apoptosis. Meanwhile, Western blot and RT-qPCR showed that the expression of NFATc1 was up-regulated in KLF15 silenced podocytes and reduced in KLF15 overexpressed podocytes. Mechanistically, ChIP analysis showed that KLF15 bound to the NFATc1 promoter region -1984 to -1861base pairs upstream of the transcription start site and the binding amount was decreased after treatment with LPS. The dual-luciferase reporter assay indicated that NFATc1 was a direct target of KLF15. In addition, we found that in vitro treatment with dexamethasone induced a decrease of NFATc1 expression in podocytes and was abrogated by knockdown of KLF15. Hence, our results identify the critical role of the KLF15-NFATc1 axis in podocyte injury and loss, which may be involved in mediating the salutary effects of dexamethasone in podocytes.

Keywords: Krüppel-like factor 15; Nuclear factor of activated T cells; injury; podocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Line
  • Dexamethasone / pharmacology
  • Down-Regulation / drug effects
  • Doxorubicin / pharmacology
  • Gene Knockdown Techniques
  • Gene Silencing / drug effects
  • Glucocorticoids / pharmacology
  • Glucocorticoids / therapeutic use*
  • Glucose / toxicity
  • Humans
  • Kruppel-Like Transcription Factors / metabolism*
  • Lipopolysaccharides / pharmacology
  • Mice
  • Models, Biological
  • NFATC Transcription Factors / metabolism*
  • Podocytes / metabolism*
  • Podocytes / pathology*
  • Proteinuria / drug therapy*
  • Proteinuria / metabolism*
  • Signal Transduction

Substances

  • Glucocorticoids
  • KLF15 protein, human
  • Kruppel-Like Transcription Factors
  • Lipopolysaccharides
  • NFATC Transcription Factors
  • Dexamethasone
  • Doxorubicin
  • Glucose